UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

New tuberculosis drug leads from naturally occurring compounds

International journal of infectious diseases, 2017-03, Vol.56 (C), p.212-220

2017

Volltextzugriff (PDF)

No smoke without fire: the impact of cigarette smoking on the immune control of tuberculosis

European respiratory review, 2022-06, Vol.31 (164), p.210252

2022

Volltextzugriff (PDF)

Biological and Biochemical Evaluation of Isatin-Isoniazid Hybrids as Bactericidal Candidates against Mycobacterium tuberculosis

Antimicrobial agents and chemotherapy, 2021-07, Vol.65 (8), p.e0001121-e0001121

2021

Volltextzugriff (PDF)

Advax adjuvant formulations promote protective immunity against aerosol Mycobacterium tuberculosis in the absence of deleterious inflammation and reactogenicity

Vaccine, 2021-04, Vol.39 (14), p.1990-1996

2021

Volltextzugriff (PDF)

Pharmacokinetics and safety of inhaled ivermectin in mice as a potential COVID-19 treatment

International journal of pharmaceutics, 2022-05, Vol.619, p.121688-121688, Article 121688

2022

Volltextzugriff (PDF)

Efficient Synthesis and Anti-Tubercular Activity of a Series of Spirocycles: An Exercise in Open Science

PloS one, 2014-12, Vol.9 (12), p.e111782-e111782

2014

Volltextzugriff (PDF)

Bengamides display potent activity against drug-resistant Mycobacterium tuberculosis

Scientific reports, 2019-10, Vol.9 (1), p.14396-10, Article 14396

2019

Volltextzugriff (PDF)

Lung IL-17A-Producing CD4 + T Cells Correlate with Protection after Intrapulmonary Vaccination with Differentially Adjuvanted Tuberculosis Vaccines

Vaccines (Basel), 2024-01, Vol.12 (2), p.128

2024

Volltextzugriff (PDF)

CXCR6-Deficiency Improves the Control of Pulmonary Mycobacterium tuberculosis and Influenza Infection Independent of T-Lymphocyte Recruitment to the Lungs

Frontiers in immunology, 2019-03, Vol.10, p.339-339

2019

Volltextzugriff (PDF)

Particulate Mycobacterial Vaccines Induce Protective Immunity against Tuberculosis in Mice

Nanomaterials (Basel, Switzerland), 2021-08, Vol.11 (8), p.2060

2021

Volltextzugriff (PDF)

CXCR3 Provides a Competitive Advantage for Retention of Mycobacterium tuberculosis-Specific Tissue-Resident Memory T Cells Following a Mucosal Tuberculosis Vaccine

Vaccines (Basel), 2023-09, Vol.11 (10), p.1549

2023

Volltextzugriff (PDF)

B-Type Natriuretic Peptide Inhibited Angiotensin II-Stimulated Cholesterol Biosynthesis, Cholesterol Transfer, and Steroidogenesis in Primary Human Adrenocortical Cells

Endocrinology (Philadelphia), 2007-08, Vol.148 (8), p.3722-3729

2007

Volltextzugriff (PDF)

Synergistic activity of phage PEV20-ciprofloxacin combination powder formulation—A proof-of-principle study in a P. aeruginosa lung infection model

European journal of pharmaceutics and biopharmaceutics, 2021-01, Vol.158, p.166-171

2021

Volltextzugriff (PDF)

Synthetic protein conjugate vaccines provide protection against Mycobacterium tuberculosis in mice

Proceedings of the National Academy of Sciences - PNAS, 2021-01, Vol.118 (4)

2021

Volltextzugriff (PDF)

CXCR3 Provides a Competitive Advantage for Retention of IMycobacterium tuberculosis/I-Specific Tissue-Resident Memory T Cells Following a Mucosal Tuberculosis Vaccine

Vaccines (Basel), 2023-09, Vol.11 (10)

2023

Volltextzugriff (PDF)

Carborane clusters increase the potency of bis-substituted cyclam derivatives against

RSC medicinal chemistry, 2022-10, Vol.13 (1), p.1234-1238

2022

Volltextzugriff (PDF)

Potent Bactericidal Antimycobacterials Targeting the Chaperone ClpC1 Based on the Depsipeptide Natural Products Ecumicin and Ohmyungsamycin A

Journal of medicinal chemistry, 2022-03, Vol.65 (6), p.4893-4908

2022

Volltextzugriff (PDF)

Carborane clusters increase the potency of bis-substituted cyclam derivatives against Mycobacterium tuberculosis

RSC medicinal chemistry, 2022-10, Vol.13 (10), p.1234-1238

2022

Volltextzugriff (PDF)

Efficient Synthesis and Anti-Tubercular Activity of a Series of Spirocycles: An Exercise in Open Science: e111782

PloS one, 2014-12, Vol.9 (12)

2014

Volltextzugriff (PDF)

Vascular endothelial growth factor trap-eye(Aflibercept) for the management of diabetic macular edema

World journal of diabetes, 2013-12, Vol.4 (6), p.303-309

2013

Volltextzugriff (PDF)

Autoimmunity is a hallmark of post-COVID syndrome

Journal of translational medicine, 2022-03, Vol.20 (1), p.129-129, Article 129

2022

Volltextzugriff (PDF)

Brolucizumab: Evolution through Preclinical and Clinical Studies and the Implications for the Management of Neovascular Age-Related Macular Degeneration

Ophthalmology (Rochester, Minn.), 2020-07, Vol.127 (7), p.963-976

2020

Volltextzugriff (PDF)

One-Year Outcomes of the DA VINCI Study of VEGF Trap-Eye in Eyes with Diabetic Macular Edema

Ophthalmology (Rochester, Minn.), 2012-08, Vol.119 (8), p.1658-1665

2012

Volltextzugriff (PDF)

Intravitreal Aflibercept for Diabetic Macular Edema

Ophthalmology (Rochester, Minn.), 2014-11, Vol.121 (11), p.2247-2254

2014

Volltextzugriff (PDF)

Metagenomic Survey of Microbes in Honey Bee Colony Collapse Disorder

Science (American Association for the Advancement of Science), 2007-10, Vol.318 (5848), p.283-287

2007

Volltextzugriff (PDF)

1 – 25 von 304

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(267)
Mit Volltextzugriff
(231)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

New tuberculosis drug leads from naturally occurring compounds

No smoke without fire: the impact of cigarette smoking on the immune control of tuberculosis

Biological and Biochemical Evaluation of Isatin-Isoniazid Hybrids as Bactericidal Candidates against Mycobacterium tuberculosis

Advax adjuvant formulations promote protective immunity against aerosol Mycobacterium tuberculosis in the absence of deleterious inflammation and reactogenicity

Pharmacokinetics and safety of inhaled ivermectin in mice as a potential COVID-19 treatment

Efficient Synthesis and Anti-Tubercular Activity of a Series of Spirocycles: An Exercise in Open Science

Bengamides display potent activity against drug-resistant Mycobacterium tuberculosis

Lung IL-17A-Producing CD4 + T Cells Correlate with Protection after Intrapulmonary Vaccination with Differentially Adjuvanted Tuberculosis Vaccines

CXCR6-Deficiency Improves the Control of Pulmonary Mycobacterium tuberculosis and Influenza Infection Independent of T-Lymphocyte Recruitment to the Lungs

Particulate Mycobacterial Vaccines Induce Protective Immunity against Tuberculosis in Mice

CXCR3 Provides a Competitive Advantage for Retention of Mycobacterium tuberculosis-Specific Tissue-Resident Memory T Cells Following a Mucosal Tuberculosis Vaccine

B-Type Natriuretic Peptide Inhibited Angiotensin II-Stimulated Cholesterol Biosynthesis, Cholesterol Transfer, and Steroidogenesis in Primary Human Adrenocortical Cells

Synergistic activity of phage PEV20-ciprofloxacin combination powder formulation—A proof-of-principle study in a P. aeruginosa lung infection model

Synthetic protein conjugate vaccines provide protection against Mycobacterium tuberculosis in mice

CXCR3 Provides a Competitive Advantage for Retention of IMycobacterium tuberculosis/I-Specific Tissue-Resident Memory T Cells Following a Mucosal Tuberculosis Vaccine

Carborane clusters increase the potency of bis-substituted cyclam derivatives against

Potent Bactericidal Antimycobacterials Targeting the Chaperone ClpC1 Based on the Depsipeptide Natural Products Ecumicin and Ohmyungsamycin A

Carborane clusters increase the potency of bis-substituted cyclam derivatives against Mycobacterium tuberculosis

Efficient Synthesis and Anti-Tubercular Activity of a Series of Spirocycles: An Exercise in Open Science: e111782

Vascular endothelial growth factor trap-eye(Aflibercept) for the management of diabetic macular edema

Autoimmunity is a hallmark of post-COVID syndrome

Brolucizumab: Evolution through Preclinical and Clinical Studies and the Implications for the Management of Neovascular Age-Related Macular Degeneration

One-Year Outcomes of the DA VINCI Study of VEGF Trap-Eye in Eyes with Diabetic Macular Edema

Intravitreal Aflibercept for Diabetic Macular Edema

Metagenomic Survey of Microbes in Honey Bee Colony Collapse Disorder

Suchergebnisse filtern